CD86 and leukemia: LEX-CD8086 transfers its intrinsic LAA and molecules and acquired costimulatory CD80 and CD86 molecules to CD4+ T cells, making CD4+ TLEX-CD8086 cells both Th1 cells and APCs capable of inducing efficient leukemia antigen-specific CD8+ CTL response.